BARCLAYS PLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 189 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$28,990,000
+856.5%
311,918
+512.7%
0.01%
+400.0%
Q3 2021$3,031,000
+335.5%
50,905
+398.7%
0.00%
Q2 2021$696,000
-89.7%
10,208
-89.6%
0.00%
-100.0%
Q1 2021$6,782,000
+20.6%
97,727
+33.5%
0.00%
+33.3%
Q4 2020$5,625,000
-27.8%
73,215
-29.7%
0.00%
-25.0%
Q3 2020$7,795,000
+69.3%
104,213
+42.6%
0.00%0.0%
Q2 2020$4,605,000
+39.6%
73,099
-6.9%
0.00%
+33.3%
Q1 2020$3,298,000
-35.6%
78,521
-30.4%
0.00%0.0%
Q4 2019$5,121,000
+124.1%
112,756
+125.8%
0.00%
+200.0%
Q3 2019$2,285,000
-37.7%
49,928
-20.1%
0.00%
-50.0%
Q2 2019$3,665,000
+185.7%
62,508
+118.2%
0.00%
+100.0%
Q1 2019$1,283,000
+1904.7%
28,645
+1649.8%
0.00%
Q4 2018$64,000
-95.8%
1,637
-95.1%
0.00%
-100.0%
Q3 2018$1,533,000
-34.7%
33,319
-38.1%
0.00%
-50.0%
Q2 2018$2,346,000
-72.1%
53,823
-74.7%
0.00%
-71.4%
Q1 2018$8,410,000
+446.1%
212,922
+369.6%
0.01%
+250.0%
Q4 2017$1,540,000
+63.7%
45,345
+22.7%
0.00%
+100.0%
Q3 2017$941,000
+266.1%
36,965
+142.0%
0.00%
Q2 2017$257,00015,2770.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Prosight Management, LP 163,133$7,467,0004.14%
PFM Health Sciences, LP 2,271,536$103,968,0003.07%
Partner Investment Management, L.P. 28,877$1,322,0002.26%
Atika Capital Management LLC 181,000$8,284,0001.74%
DAFNA Capital Management LLC 93,942$4,300,0001.62%
Asymmetry Capital Management, L.P. 16,272$745,0001.60%
First Light Asset Management, LLC 190,838$8,735,0001.32%
Perceptive Advisors 953,129$43,624,0001.18%
Rhenman & Partners Asset Management AB 155,000$7,094,0000.89%
Opus Point Partners Management, LLC 9,770$447,0000.81%
View complete list of ARENA PHARMACEUTICALS INC shareholders